Latest Trials Latest NewsFAQ

UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer

Not Applicable

Completed

Conditions: Adenocarcinoma of Prostate

Interventions: Behavioral: Dashboard

First Posted Date: 2015-01-21

Last Posted Date: 2018-01-09

Lead Sponsor: University of Rochester

Target Recruit Count: 140

Registration Number: NCT02342626

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

TTE and Dysphagia in Anterior Cervical Surgery

Not Applicable

Active, not recruiting

Conditions: Dysphagia

Interventions: Other: Trachael Preparation Education

First Posted Date: 2014-12-25

Last Posted Date: 2024-04-02

Lead Sponsor: University of Rochester

Target Recruit Count: 150

Registration Number: NCT02326116

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax

Not Applicable

Completed

Conditions: Sjogren's Disease

Interventions: Drug: Administration of Lotemax

First Posted Date: 2014-12-23

Last Posted Date: 2015-10-16

Lead Sponsor: University of Rochester

Target Recruit Count: 10

Registration Number: NCT02322528

Locations: 🇺🇸
Flaum Eye Institute at the University of Rochester, Rochester, New York, United States

Multicenter Observational Study of Myotonic Dystrophy Type 1

Completed

Conditions: Myotonic Dystrophy Type 1

First Posted Date: 2014-12-04

Last Posted Date: 2017-10-26

Lead Sponsor: University of Rochester

Target Recruit Count: 120

Registration Number: NCT02308657

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
University of Rochester, Rochester, New York, United States

and more 3 locations

The Leaky Lung Test

Early Phase 1

Completed

Conditions: Allergy
Asthma
Reactive Airway Disease
Lung Diseases, Obstructive

Interventions: Drug: Mannitol

First Posted Date: 2014-12-03

Last Posted Date: 2018-01-04

Lead Sponsor: University of Rochester

Target Recruit Count: 100

Registration Number: NCT02306473

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Peer Led Asthma Self Management for Adolescents: PLASMA

Phase 2

Completed

Conditions: Asthma

Interventions: Behavioral: PLASMA

First Posted Date: 2014-11-18

Last Posted Date: 2021-04-08

Lead Sponsor: University of Rochester

Target Recruit Count: 371

Registration Number: NCT02293499

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
University at Buffalo, Buffalo, New York, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

and more 1 locations

Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy

Not Applicable

Terminated

Conditions: Clostridium Difficile
Prostate Cancer
Urinary Tract Infection

Interventions: Drug: Ciprofloxacin

First Posted Date: 2014-09-25

Last Posted Date: 2017-04-17

Lead Sponsor: University of Rochester

Target Recruit Count: 175

Registration Number: NCT02247960

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities

Phase 1

Completed

Conditions: Abscess

Interventions: Drug: Methylene Blue
Drug: 20% I.V. Fat Emulsion
Device: Insertion of optical fiber
Device: Laser illumination, 5 minutes
Device: Laser illumination, 10 minutes
Device: Laser illumination, 15 minutes
Device: Laser illumination, 20 minutes
Device: Laser illumination, 25 minutes
Device: Laser illumination, 30 minutes
Device: Optical spectroscopy measurement

First Posted Date: 2014-09-15

Last Posted Date: 2024-03-06

Lead Sponsor: University of Rochester

Target Recruit Count: 21

Registration Number: NCT02240498

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Macular Degeneration and Aging Study

Not Applicable

Completed

Conditions: Age-related Macular Degeneration

Interventions: Behavioral: Preventive Problem-Solving Training
Behavioral: Life and Health Review

First Posted Date: 2014-08-25

Last Posted Date: 2019-04-16

Lead Sponsor: University of Rochester

Target Recruit Count: 216

Registration Number: NCT02224963

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Enzalutamide and Dutasteride or finasteride

First Posted Date: 2014-08-11

Last Posted Date: 2024-11-13

Lead Sponsor: University of Rochester

Target Recruit Count: 43

Registration Number: NCT02213107

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
Medical College of Wisconscin, Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy